#Japan #Medical Affairs #Nihonbashi #healthcare delivery #DDCP

Exploring the New Textbook on Medical Affairs

The pharmaceutical and medical device industries are on the cusp of a significant transformation with the upcoming release of a pivotal textbook titled 'Medical Affairs Science: Studying Every Path of Drug Delivery to Patients', which is slated for publication in July 2026. This groundbreaking text will serve as a comprehensive guide aimed at medical professionals—including physicians, pharmacists, and researchers—who are engaged in optimizing patient treatment through innovative initiatives known as Medical Affairs.

The spotlight on Medical Affairs was particularly pronounced during the 17th Annual Meeting of the Japan Pharmaceutical Medical Association, held on July 24-25, 2026, in Nihonbashi. During sessions such as ‘Defining and Measuring Desired Medical Affairs Activities,’ panelists strongly advocated for addressing Medical Affairs as an academic discipline.

The book seeks to unify and formalize the disparate approaches to Medical Affairs, describing it as a science focused on the process of ensuring that medications effectively reach patients. It covers topics integral to the field, including medical strategy, evidence generation, real-world data utilization, Medical Science Liaison (MSL) activities, Key Performance Indicators (KPI), and even the integration of AI technologies into practice.

Central to the book's mission is the aspiration to share and implement a scientific, neutral, and patient-first philosophy with stakeholders both inside and outside the organization. This includes navigating global communication effectively. The Drug Development Capability Promotion Organization (DDCP) has played a crucial role in compiling this essential resource, crafting it specifically for upcoming science leaders who will shape the future of healthcare practices.

The textbook is highly recommended for various professionals:

• - Medical Science Liaisons can harness it to engage in insightful discussions with leading healthcare practitioners, helping to uncover unmet medical needs.
• - Medical Leads will find it invaluable in enhancing their understanding of unmet needs and developing impactful, strategic solutions.
• - Medical Information, Publication, and Evidence Generation Staff can utilize it to discern how different initiatives can coalesce into a powerful and effective medical plan.
• - Professionals from Other Departments, including development, marketing, and sales, can leverage insights to foster stronger synergies with Medical Affairs.
• - Students in Pharmacy, Medicine, and Life Sciences will find inspiration and guidance to explore careers in Medical Affairs and MSL roles.

Author Backgrounds

The book features contributions from notable figures such as Taku Seriu, the Executive Director of DDCP, who also serves as a senior advisor at APCER Life Sciences. He is joined by Hiroshi Tamada, DDCP Director and CEO of Nassau Biopharma Consulting, and Tomoko Chubachi, founding director of DDCP and president of TMC Clinical Development Consulting, among others.

The response to the book is expected to be overwhelmingly positive, as there has already been significant interest from pharmaceutical companies, academia, and CROs.

For media inquiries or to arrange author interviews, please reach out to:
Medical Science International Co., Ltd.
Email: [email protected]
Phone: 03-5804-6051
Fax: 03-5804-6055

The publisher, Medical Science International Co., Ltd., is renowned for distributing essential medical literature including titles such as 'Harrison's Principles of Internal Medicine', 'Kandel's Neuroscience', and more.